|
RAP1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.55509963082079E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.36489749794578E-11 |
| Normal-vs-Stage2 |
3.620200E-03 |
| Normal-vs-Stage3 |
3.81100000002021E-06 |
| Normal-vs-Stage4 |
1.367620E-04 |
| Stage1-vs-Stage2 |
4.050000E-02 |
| Stage1-vs-Stage3 |
9.481800E-01 |
| Stage1-vs-Stage4 |
7.816800E-01 |
| Stage2-vs-Stage3 |
8.992200E-02 |
| Stage2-vs-Stage4 |
2.346600E-01 |
| Stage3-vs-Stage4 |
7.791400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.60720359032985E-11 |
| Normal-vs-AfricanAmerican |
2.09949999996351E-06 |
| Normal-vs-Asian |
2.314000E-01 |
| Caucasian-vs-AfricanAmerican |
1.261640E-01 |
| Caucasian-vs-Asian |
3.923800E-01 |
| AfricanAmerican-vs-Asian |
8.069200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.86849466191575E-11 |
| Normal-vs-Female |
1.54472999999156E-05 |
| Male-vs-Female |
4.193900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.17909999833799E-08 |
| Normal-vs-Extreme_Weight |
4.74399963756866E-10 |
| Normal-vs-Obese |
3.1636000041857E-08 |
| Normal-vs-Extreme_Obese |
3.704000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.458400E-01 |
| Normal_Weight-vs-Obese |
5.717800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.241000E-01 |
| Extreme_Weight-vs-Obese |
4.243200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.085400E-01 |
| Obese-vs-Extreme_Obese |
5.994000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.412900E-04 |
| Normal-vs-Age(41-60Yrs) |
4.10180001075844E-09 |
| Normal-vs-Age(61-80Yrs) |
9.71980274044881E-11 |
| Normal-vs-Age(81-100Yrs) |
2.06430000004865E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.790800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.692200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.329000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.989000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.467200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.645400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.01790029130677E-10 |
| Normal-VS-Type2 PRCC |
5.58690005370011E-09 |
| Normal-VS-KIRP CIMP |
2.121200E-03 |
| Normal-VS-Unclassified PRCC |
1.036800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.709000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.370200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.725800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.350600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.595800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.625200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.65199999633015E-08 |
| Normal-vs-N1 |
1.598310E-04 |
| Normal-vs-N2 |
3.795900E-04 |
| N0-vs-N1 |
6.327000E-01 |
| N0-vs-N2 |
5.044800E-01 |
| N1-vs-N2 |
4.220800E-01 |
|
|
